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 Abstract 
          An international advisory group met at the National Institutes of Health in 
Bethesda, Maryland in 2017, to discuss a new classification system for the ectodermal 
dysplasias that would integrate both clinical and molecular information.  We propose the 
following, a working definition of the ectodermal dysplasias building on previous 
classification systems and incorporating current approaches to diagnosis:  ectodermal 
dysplasias are genetic conditions affecting the development and/or homeostasis of two or 
more ectodermal derivatives, including hair, teeth, nails, and certain glands. Genetic 
variations in genes known to be associated with ectodermal dysplasias that affect only 
one derivative of the ectoderm (attenuated phenotype) will be grouped as non-syndromic 
traits of the causative gene (e.g. non-syndromic hypodontia or missing teeth associated 
with pathogenic variants of EDA “ectodysplasin” ). Information for categorization and 
cataloging includes the phenotypic features, Online Mendelian Inheritance in Man 
number, mode of inheritance, genetic alteration, major developmental pathways involved 
(e.g. EDA, WNT “wingless-type”, TP63 “tumor protein p63”) or the components of 
complex molecular structures ( e.g. connexins, keratins, cadherins). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Introduction 
Ectoderm gives rise to the epidermis, the central and peripheral nervous system, 
the placodes (including cranial placodes), and neural crest cells. Cell fate decisions that 
lead to ectodermal lineage specification are regulated by highly conserved signaling 
pathways such as the WNT, BMP “bone morphogenic protein, and FGF “fibroblast 
growth factor” pathways.[Patthey and Gunhaga 2014]  Ectodermal appendages (e.g. hair, 
teeth, nails) arise from signaling cross-talk interactions between ectodermal epithelium 
and mesenchyme.[Naveau and others 2014]  Numerous hereditary conditions are 
characterized by abnormal development of ectodermal tissues.  Classification and 
nosology for these conditions exist to guide clinicians in deriving a correct diagnosis and 
aid in communicating with patients and investigators.  Ideally, these classification 
systems and approaches should be useful for diverse stakeholders including students, 
patients, researchers, and clinicians. 
Hereditary conditions historically classified as an ectodermal dysplasia (ED) are 
heterogeneous in their genetic causes and clinical phenotypes.  A unifying feature is that 
all of the ED conditions are genetically determined developmental defects of tissues of 
ectodermal origin.  Initial classification systems for the EDs predate molecular genetics 
and were categorized and grouped according to phenotypic features and mode of 
inheritance.  The most widely known such nosology was developed by Dr. Newton 
Freire-Maia in the 1970s and included conditions with “classical signs” involving hair, 
teeth, nails, and/or sweat glands.[Freire-Maia 1971; Freire-Maia 1977; Freire-Maia and 
Pinheiro 1984; Freire-Maia and Pinheiro 1988]  The disorders were subdivided into 
Group A – those having at least two of these tissues affected – and Group B – conditions 
affecting one of the aforementioned tissues and at least one other tissue of ectodermal 
origin (e.g. mammary gland).[Freire-Maia and Pinheiro 1984; Nguyen-Nielsen and others 
2013] The Freire-Maia classification system serves as a strong foundation that has 
advanced our understanding of these diverse conditions and provided valuable 
information on how best to manage affected individuals. 
While the ectodermal dysplasias are considered rare conditions, there are 
contradictory reports on their prevalence.  A nationwide cross-sectional study in 
Denmark that leveraged data from national registries and clinical departments suggests 
that X-linked hypohidrotic ED (XLHED; MIM #305100) may be more common than 
previously thought.[Nguyen-Nielsen and others 2013]  The authors reported a possible 
1224 HED cases between 1995 and 2010 with 90 of these confirmed at the molecular 
level, 146 clinically diagnosed, and 988 possible HED cases.  The prevalence of 
molecularly confirmed XLHED was 1.6:100,000.[Nguyen-Nielsen and others 2013] 
Although the historical nosological grouping of the EDs was predicated on 
phenotype, our understanding of the human genome and its role in development and 
disease has advanced providing new opportunities to recognize how some conditions are 
related at the molecular level. [Freire-Maia 1977]; [Itin 2014; Wright and others 2009]  
The first genetic alteration identified as causative for ED was a loss-of-function variant of 
the gene EDA.[Kere and others 1996]  Following this discovery, the causes of other 
hypohidrotic ED conditions with similar phenotypes were discovered in defects of the 
EDA receptor (EDAR) and the adaptor proteins EDARADD “EDAR-associated death 
domain” [Headon and others 2001] and TRAF6 “TNF receptor-associated factor 6”. 
[Wisniewski and Trzeciak 2012] [Chassaing and others 2006]  Pathogenic alterations in 
any of these genes can result in a clinical phenotype similar to XLHED, and both 
heterozygosity and compound heterozygosity or homozygosity for these can cause the 
disorders. Subsequently, genetic alterations in genes associated with other ED types were 
discovered in the NFkB pathway that plays a variety of roles in normal ectodermal tissue 
development. The genetic basis for nearly 50% of conditions historically classified as 
EDs and the causative genetic alterations underlying most of the more prevalent ED 
conditions are known.[Pagnan and Visinoni 2014; Wright and others 2009]   Further, it is 
now clear that many of the genes affected in EDs function in common molecular 
pathways that are known to be of importance in development of the ectodermal 
derivatives (e.g. NFkB “nuclear factor kappa-B”, WNT, TP63 pathways).[Cluzeau and 
others 2011; Kantaputra and Carlson 2018; Koster 2010]   
Developing a classification system that incorporates the molecular etiology and 
the molecular pathway will help clinicians about the diagnosis of the diverse ED 
conditions at both the clinical and genetics levels.[Itin 2014]  Understanding the 
molecular pathogenesis of the EDs will better inform researchers as to phenotypic 
features often associated with specific pathways thereby illuminating potential causative 
candidate genes for ED conditions undiagnosed at the molecular level (e.g. TP63 
pathway-associated phenotypes include features such as cleft lip/palate and hand/foot 
malformations).[Koster 2010; Vera-Carbonell and others 2012]  
 The National Foundation for Ectodermal Dysplasias (NFED) embarked on 
developing a new classification system through a series of conferences that brought 
together stakeholders and international experts.  Dr. Carlos Salinas chaired two 
conferences in Charleston, South Carolina, in 2008 and 2012; with the proceedings 
published in the American Journal of Medical Genetics.[Salinas and others 2014; Salinas 
and others 2009]  In 2017, an international working group of individuals, many of whom 
had participated in the previous conferences, met on the National Institutes of Health 
campus in Bethesda, Maryland.  The outcome of these meetings was a refined definition 
of what comprises an ectodermal dysplasia for developing a classification approach that 
would incorporate phenotype, inheritance, and molecular etiology including 
developmental pathway or structural assembly to organize and cluster the ED conditions. 
 
Definition of Ectodermal Dysplasias 
A broad variety of tissues such as the central and peripheral nervous system, 
adenohypophysis, lens, olfactory epithelium, parts of the pharyngeal arches, pigmented 
cells, epidermis, and mucosal epithelium are of ectodermal origin.  The definition for 
inclusion as an ectodermal dysplasia does not extend to all derivatives of ectoderm and is 
most often limited to conditions affecting the skin and mucosa and/or their 
appendages.[Freire-Maia 1977; Itin 2013; Pagnan and Visinoni 2014]  Based on 
recommendations from the previous classification conferences, the group developed 
consensus on the following working definition of ectodermal dysplasia for the purposes 
of this classification system:  Ectodermal dysplasias are genetic conditions affecting the 
development and/or homeostasis of two or more ectodermal derivatives, including hair, 
teeth, nails, and certain glands.  The molecular causes of these diverse conditions involve 
many genes and multiple developmental pathways and components of complex molecular 
structures that are necessary for normal formation, structure, and function of the 
ectodermal derivatives.  It should be noted that in some ectodermal dysplasias there are 
disturbances of epithelial-mesenchymal interaction affecting endodermal as well as 
ectodermal structures, such as the defects of mucous gland formation in the lung and the 
colon in XLHED.  
Numerous genes may have alterations that are associated with syndromes while in 
other instances they are associated with changes in only one ectodermal tissue.  Examples 
of this include EDA and WNT10A “wingless-type 10A” variants that result in missing 
teeth but no other phenotypic features of ED.[van den Boogaard and others 2012; Yang 
and others 2013]  Genetic alterations of ED-associated genes that only affect one 
derivative of ectoderm (e.g. hair, teeth, nails, sweat glands) should be grouped as non-
syndromic traits of the causative gene (e.g. non-syndromic hypodontia or missing teeth 
associated with pathogenic EDA variants).  It is further noted that not all pathogenic 
mutations in a given gene may cause an ectodermal dysplasia. For example, mutations in 
GJB2 “gap junction protein beta-2”, a gene coding for connexin, can give rise to isolated 
deafness, palmoplantar keratoderma, and ichthyosis, as well as K-I-D syndrome 
(kearatitis-icthyosis-deafness syndrome). 
Inclusion/Exclusion 
The development of a useful nosology based on the above definition of ED involved 
establishing inclusion and exclusion criteria.  Conditions were included if they met the 
adopted definition of an ectodermal dysplasia.    Conditions already included as part of 
other classifications or groups of diseases and/or are presented in different chapters in 
textbooks (e.g. palmoplantar keratodermas such as Papillon-Lefèvre syndrome (OMIM 
#245000), disorders of DNA repair such as trichothiodystrophy, vesiculobullous 
disorders) were not included, although they may be associated with alterations in 
ectodermal structures.[Fine and others 2014; Lucker and others 1994]  Complex 
syndromes that have ED signs but also major non-ED signs (e.g. affecting bone, brain) 
were also excluded (e.g. trisomy 21).  Finally, the group agreed to exclude conditions 
listed in OMIM with only one case report and no known molecular etiology. 
Classification Scheme and Clustering 
 The proposed ED classification system comprises information from multiple domains 
including OMIM #, phenotype, mode of inheritance, causal gene, and molecular pathway 
or structure.  Conditions are grouped based on genotype, molecular pathway and 
phenotype.  The clinician is likely to assort these disorders based on the physical features 
while the molecular geneticist may think in terms of pathways. A classification system 
should be a useful tool irrespective of the user’s entry point. Knowledge of 
developmental pathways and molecular structures, and the relationship of different gene 
products within these domains, show that many EDs result from genes that co-participate 
in critical developmental processes and structural assemblages of the ectodermal 
derivatives (Figures 1, 2, 3).  In these figures the EDA associated genes are presented in 
orange ovals, WNT associated genes are presented in purple ovals, and TP63 associated 
genes are presented in blue ovals.  These pathway figures also illustrate how different 
pathways can be interconnected (Figure 1 – TP63 genes interacting with EDA pathway 
genes). Other genes and their genetic variants associated with EDs code for proteins 
important for the structure and/or function of cells.  Table 1 illustrates this organizational 
system showing how ED conditions are clustered based on the gene, molecular pathway, 
and/or protein function and how these different domains are ordered to provide relevant 
information.   The full list of the known ED conditions included is available in the 
electronic supplement (Table 2e).  The conditions are ordered within clusters based on 
the most proximal or up-stream gene involved with down-stream genes in the pathway 
following (e.g. EDA, EDAR, IKBKG “inhibitor of kappa light plypeptide gene enhance in 
B cells”). In the case of EDA, this also happens to coincide with XLHED being the most 
prevalent form of HED.  As ED prevalence remains poorly characterized, meaningful 
ordering or reporting based on frequency of occurrence in the population is difficult. 
Conditions meeting the definition of an ED but of unknown etiology are grouped with 
other EDs that share the most similar phenotype.  Identifying the molecular basis of these 
conditions will allow classification with existing ED clusters or, based on the molecular 
etiology, to become the anchor of a new ED cluster. 
Discussion 
The omics era ushered in entirely new and rapidly developing areas of knowledge 
that continue to change our view of health and disease.  Conditions previously thought to 
be unrelated can result from allelic mutations that lead to markedly different clinical 
phenotypes (e.g. TP63-associated syndromes).[Rostagno and others 2010; Wisniewski 
and Trzeciak 2012]   Prior to the explosion of knowledge in the molecular era, the 
foundation for classifying conditions was phenotype and mode of inheritance.  More 
recent classificatory approaches include a variety of molecular data that aids in 
understanding the relationship of the underlying molecular defect, protein alteration and 
resulting phenotype.  For example, the inherited epidermolysis bullosa conditions are 
clustered based on the histological level of tissue separation, the clinical phenotype, the 
gene involved and, when possible, the specific genetic alteration.[Fine and others 2014]  
Other classification systems, such as the nosology proposed for inherited ichthyosis, 
remain clinically based.[Oji and others 2010]  The international ichthyosis workgroup 
recognized, however, that a pathophysiologic classification of inherited ichthyoses should 
be developed as additional information becomes available. The Nosology Group of the 
International Skeletal Dysplasia Society clusters conditions based on their molecular 
basis as well as using phenotype clustering.[Bonafe and others 2015] 
 Classification systems for ED have been proposed that categorize the conditions 
within groups based on the underlying functional defect such as abnormal developmental 
regulation or structural protein.[Priolo and Lagana 2001]  We are aware that the proposed 
ED nosology will require additions and modifications due to the identification of new 
genes and genetic alterations.  Nonetheless, we believe that this current construct has 
utility for the clinician struggling with a differential diagnosis and the researcher hoping 
to elucidate underlying causality. With the therapeutic management of XLHED now a 
reality, through the intra-amniotic delivery of a fusion protein that substitutes for the 
function of the abnormal EDA protein, the need to establish the correct diagnosis of the 
EDs has never been greater.[Schneider and others 2018]   
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Figures: 
Figure 1:  The EDA molecular pathways and the interrelationships between different 
genes and known associated EDs are presented.  Causative genes appear in orange ovals 
and abbreviations for the ED conditions are shown in green boxes. 
Figure 2:  The WNT molecular pathways and the interrelationships between different 
genes are presented.  Causative genes appear in purple ovals and abbreviations for the ED 
conditions are shown in green boxes. 
 Figure 3:  TP63 molecular pathways and the interrelationships between different genes 
are presented. Causative genes appear in blue ovals and abbreviations for the ED 
conditions are shown in green boxes.   
 
 
 
 
  
Table 1.  Organization of ED conditions based on molecular pathways  
EDA/NFKappaB 
Pathway    
OMIM Number Syndrome Name(s) Gene Distinguishing Features 
305100 
Hypohidrotic Ectodermal 
Dysplasia; ED1; Christ-
Siemens-Touraine 
Syndrome 
Ectodysplasin A; 
EDA (300451) 
Hypohidrosis, hypotrichosis, 
hypodontia, smooth dry skin, 
craniofacial dysmorpholgy, 
periorbital pigmentation 
129490 
Hypohidrotic Ectodermal 
Dysplasia 10A 
Ectodysplasin A 
Receptor EDAR 
(604095) or 
EDARADD 
(606603) 
Hypohidrosis, hypotrichosis, 
hypodontia, smooth dry skin, 
craniofacial dysmorphology, 
periorbital pigmentation 
224900 
Hypohidrotic Ectodermal 
Dysplasia 10B 
Ectodysplasin A 
Receptor EDAR 
(604095) or 
EDARADD 
(606603) 
Hypohidrosis, hypotrichosis, 
hypodontia, smooth dry skin, 
craniofacial dysmorpholgy, 
periorbital pigmentation 
308300 
Incontinentia Pigmenti; 
IP 
IKBKG  
(300248) 
Short stature, cataract, 
micropthalmia,, hypodontia, 
extra ribs, breast aplasia, 
staged skin involvement, nail 
dystrophy, atrophic hair 
300291 
Ectodermal Dysplasia 
and Immunodeficiency 
1: EDAID1 
IKBKG  
(300248) 
Hypohidrosis, hypotrichosis, 
morbidity/mortality 
secondary to 
immunodeficiency  
    
WNT Pathway    
OMIM Number Syndrome Name(s) Gene Distinguishing Features 
305600 
Focal Dermal 
Hypoplasia, Goltz 
Syndrome 
PORCN 
(300651) 
Short stature, facial 
asymmetry, narrow auditory 
canals, hearing loss, oral 
papillomas, hypodontia, 
syndactyly, sparse hair, skin 
atrophy 
257980 
Odontoonychodermal 
Dysplasia; OODD WNT10A (606268) 
sparse eyebrows, severe 
hypodontia, smooth tongue, 
hyperhidrosis, 
hyperkeratosis, dystrophic 
nails, sparse eyebrows, thin 
hair 
224750 
Schopf-Schulz-Passarge 
Syndrome WNT10A (606268) 
hypodontia, eyelid cysts, 
keratoderma, hypoplastic 
nails, hypotrichosis 
    
TP63 Pathway    
OMIM Number Syndrome Name(s) Gene Distinguishing Features 
103285 
Acro-Dermato-Ungual-
Lacrimal-Tooth 
Syndrome (ADULT 
Syndrome) 
TP63  
(603273) 
Lacrimal obstruction, 
hypodontia, dysplastic teeth, 
breast hypoplasia, 
ectrodactyly, thin skin, 
dysplastic nails 
106260 
Ankyloblepharon-
Ectodermal Defects-
Cleft Lip/Palate (AEC; 
Hay-Wells Syndrome)  
TP63  
(603273)) 
scalp erosions, conductive 
hearing loss, maxillary 
hypoplasia,  lacrimal duct 
atresia, hypotrichosis, 
ankyloblepharon, cleft l/p, 
hypodontia 
129400 
Rapp-Hodgkin 
Syndrome 
TP63  
(603273) 
short stature, maxillary 
hypoplasia, hearing loss, cleft 
l/p, hypodontia,  
syndactyly, thin skin, 
hypohidrosis 
604292 
Ectrodactyly, Ectodermal 
Dysplasia, and Cleft 
Lip/Palate Syndrome 3; 
EEC3 
TP63  
(603273) 
blepharophimosis, cleft l/p, 
microdontia, hypodontia, 
syndactyly, hypokeratosis, 
dystrophic nails 
hypotrichosis 
603543 
Limb-Mammary 
Syndrome; LMS 
TP63 
(603273) 
lacrimal duct atresia, 
hypodontia cleft p, 
hypoplastic breasts, 
syndactyly, ectrodactyly, nail 
dysplasia 
    
Structure Group    
OMIM Number Syndrome Name(s) Gene Distinguishing Features 
225280 
 
Ectodermal dysplasia, 
ectrodactyly, and  
macular dystrophy 
syndrome; EEMS 
 
CDH3 
Cadherin 3 
(114021) 
 
 
Sparse scalp hair, eyebrows 
and eyelashes, hypodontia, 
small teeth, ectrodactyly, 
syndactyly, camptodactyly, 
normal sweating 
602032 
 
Ectodermal dysplasia 4, 
hair/nail type ; ECTD4 
 
KRT85  
Keratin 85 (602767) 
 
Nail dystrophy, onycholysis, 
absent eybrows/eyelashes, 
alopecia,  normal skin/teeth 
604536 
 
Ectodermal 
dysplasia/skin fragility 
syndrome 
 
PKP1 
Plakophilin 1 
(601975) 
 
Nail dystrophy and 
thickening, hypotrichosis, 
sweat glands, skin fragility  
158000 
 
Monilethrix 
 MNLIX 
 
Keratins 81, 86, 83 
KRT81, KRT86, 
KRT83 
(602153, 601928 
602765) 
Follicular keratosis, nail 
dystrophy, hypotrichosis, 
brittle hear 
225060 
Cleft lip/Palate-
Ectodermal Dysplasia 
(CLPED1)  
Nectin 1, 
NECTIN1(600644) 
Malar hypoplasia, 
hypotrichosis, cleft lip/palate, 
hypodontia, syndactyly, 
onychodysplasia 
 
   
Other/Unknown     
OMIM Number Syndrome Name(s) Gene Distinguishing Features 
601701 
Arthorgryposis and 
Ectodermal Dysplasia Unknown 
Short statue, microcephaly, 
cataract, cleft lip/palate, 
oligodontia, enamel defects, 
arthrogryposis, hypohidrosis, 
onychodysplasia 
125640 Dermoonontodysplasia Unknown 
trichodysplasia, 
onychodysplasia, dental 
anomalies 
. 
 
